Continuous Glucose Monitoring Systems Market by Components, Demographics (Child Population, and Adult Population, and End User : Global Opportunity Analysis and Industry Forecast, 2020–2027
Continuous Glucose Monitoring Systems Market by Components (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (<=14years), and Adult Population (>14years), and End User (Clinics and Diagnostics Centers, ICUs, and Home Healthcare): Global Opportunity Analysis and Industry Forecast, 2020–2027
The global continuous glucose monitoring systems (CGMS) market size was valued at $1,774.2 million in 2019, and is projected to reach $8,844.9 million by 2027, registering a CAGR of 22.0% during the forecast period. Continuous glucose monitoring systems help to manage diabetes by providing real time values of the glucose levels and alert the patient in the event of hypo or hyperglycemia. This helps reduce the probability of any complications related to diabetes. In addition, CGMS offers varied benefits over other glucose monitors in monitoring the blood glucose levels of ICU patients. Increase in adoption of continuous glucose monitoring systems in home care applications and rise in incidence of diabetes are the major factors that drive the market growth. However, reimbursement and stringent regulatory issues in developing countries is anticipated to restrain the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a CAGR of 20.0% from 2020 to 2027. On the contrary, emerging markets are anticipated to offer significant growth opportunities for the market players in the future.
KEY BENEFITS FOR STAKEHOLDERS - This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities. - An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans. - A comprehensive analysis of the factors that drive and restrain the growth of the global digital therapeutics market is provided. - An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS • By Component o Sensors o Transmitters & Receivers o Integrated Insulin Pumps
By Demographics • Child Population (?14 years) • Adult Population (>14 years)
By End User • Diagnostics/Clinics • ICUs • Home Healthcare
By Region o North America • U.S. • Canada • Mexico o Europe • UK • Germany • France • Spain • Italy • Netherlands • Norway • Sweden • Denmark • Finland • Rest of Europe o Asia-Pacific • China • India • Australia • Japan • South Korea • Rest of Asia-Pacific o LAMEA • Brazil • Venezuela • Saudi Arabia • South Africa • Argentina • Rest of LAMEA
KEY MARKET PLAYERS • 2MORROW, Inc. • Fitbit, Inc. (Twine Health, Inc.) • Livongo Health, Inc. • Medtronic Plc. • OmadaHealth, Inc. • Pear Therapeutics, Inc. • Proteus Digital Health, Inc. • Resmed, Inc. (Propeller Health) • Voluntis, Inc. • Welldoc, Inc.
The other players in the value chain include (profiles not included in the report): • Canary Health Inc. • Mango Health Inc. • Noom, Inc. • Dthera Sciences
Our reports have been used by over 10K customers, including:
Diabetes has emerged as a global epidemic and has afflicted millions of population, worldwide. While Type-1 diabetes is caused by an immune system malfunction, Type-2 diabetes is linked to leading a sedentary lifestyle, which results in the development of inherent resistance to insulin. Hence, Type-1 diabetes can be characterized as insulin-requiring,...
Artificial Pancreas Device System Market Research Report by Device Type (Control-to-Range System, Control-to-Target System, and Threshold Suspended Device System), by Treatment Type (Bi-hormonal, Hybrid, and Insulin Only), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Blood Glucose Test Strips Market Research Report by Technology (Channel Technology and Wicking Technology), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast...
Blood Glucose Meters - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Blood Glucose Meters - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Blood Glucose Meters pipeline products with comparative analysis of the products...
Diabetes Assays - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Diabetes Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Diabetes Assays pipeline products with comparative analysis of the products at various stages...
Executive Summary According to the report, the Global Continuous Glucose Monitor Market is projected to display significant growth represented by a CAGR of 17.24% during 2020 - 2025. The Global Continuous Glucose Monitoring Market was valued at USD 4245.67 million in the year 2019 with North America leading the regional...
Global Self-Monitoring Blood Glucose Devices Market by Product (Test Strips, Lancets, and Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and End User (Hospitals, Home Settings, and Diagnostic Centers): Opportunity Analysis and Industry Forecast, 2020–2027 The global...
Report Scope: The report will analyze the leading manufacturers of home health monitoring devices from the U.S., Europe, Asia-Pacific markets and emerging markets. The report will study these companies along various factors such as their last year’s growth, research & development and future plans and forecasts through 2025....
The global home healthcare market size is projected to reach USD 274.7 billion by 2025 from USD 181.9 billion in 2020, at a CAGR of 8.6% during the forecast period. The market growth is mainly driven by factors such as the rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare...
BRIC CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter), Diabetes (Type1 & 2) Population, & Forecast The BRIC CGM market witnessed strong growth in recent decades and is further expected to grow primarily due to the increasing adaptation of continuous glucose monitoring devices...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.